307 related articles for article (PubMed ID: 26407972)
1. Pseudomonas aeruginosa: breaking down barriers.
Berube BJ; Rangel SM; Hauser AR
Curr Genet; 2016 Feb; 62(1):109-13. PubMed ID: 26407972
[TBL] [Abstract][Full Text] [Related]
2. The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia.
Rangel SM; Diaz MH; Knoten CA; Zhang A; Hauser AR
PLoS Pathog; 2015 Jun; 11(6):e1004945. PubMed ID: 26090668
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
[TBL] [Abstract][Full Text] [Related]
4. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
[TBL] [Abstract][Full Text] [Related]
5.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
6. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.
Kikuchi Y; Tateda K; Fuse ET; Matsumoto T; Gotoh N; Fukushima J; Takizawa H; Nagase T; Standiford TJ; Yamaguchi K
Pulm Pharmacol Ther; 2009 Aug; 22(4):333-9. PubMed ID: 19162211
[TBL] [Abstract][Full Text] [Related]
7. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
Shaver CM; Hauser AR
Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
[TBL] [Abstract][Full Text] [Related]
8. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
Lee VT; Smith RS; Tümmler B; Lory S
Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
[TBL] [Abstract][Full Text] [Related]
9. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.
Guillon A; Brea D; Morello E; Tang A; Jouan Y; Ramphal R; Korkmaz B; Perez-Cruz M; Trottein F; O'Callaghan RJ; Gosset P; Si-Tahar M
Virulence; 2017 Aug; 8(6):810-820. PubMed ID: 27792459
[TBL] [Abstract][Full Text] [Related]
11. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.
Schulert GS; Feltman H; Rabin SD; Martin CG; Battle SE; Rello J; Hauser AR
J Infect Dis; 2003 Dec; 188(11):1695-706. PubMed ID: 14639541
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.
Anantharajah A; Faure E; Buyck JM; Sundin C; Lindmark T; Mecsas J; Yahr TL; Tulkens PM; Mingeot-Leclercq MP; Guery B; Van Bambeke F
J Infect Dis; 2016 Oct; 214(7):1105-16. PubMed ID: 27412581
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Wagener BM; Hu R; Wu S; Pittet JF; Ding Q; Che P
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822560
[No Abstract] [Full Text] [Related]
14. IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia.
Katoh H; Yasumoto H; Shimizu M; Hamaoka S; Kinoshita M; Akiyama K; Sawa T
Crit Care Med; 2016 Jan; 44(1):e12-24. PubMed ID: 26317571
[TBL] [Abstract][Full Text] [Related]
15. PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice.
Goolaerts A; Lafargue M; Song Y; Miyazawa B; Arjomandi M; Carlès M; Roux J; Howard M; Parks DA; Iles KE; Pittet JF
Thorax; 2011 Sep; 66(9):788-96. PubMed ID: 21768189
[TBL] [Abstract][Full Text] [Related]
16. The great escape:
Zhang A; Rangel SM; Hauser AR
Microb Cell; 2015; 2(10):409-411. PubMed ID: 27077073
[TBL] [Abstract][Full Text] [Related]
17. Early Cytokine Induction Upon
Kolbe U; Yi B; Poth T; Saunders A; Boutin S; Dalpke AH
Front Immunol; 2020; 11():598636. PubMed ID: 33250899
[TBL] [Abstract][Full Text] [Related]
18. DeaD contributes to Pseudomonas aeruginosa virulence in a mouse acute pneumonia model.
Tan H; Zhang L; Zhao Q; Chen R; Liu C; Weng Y; Peng Q; Bai F; Cheng Z; Jin S; Wu W; Jin Y
FEMS Microbiol Lett; 2016 Oct; 363(20):. PubMed ID: 27682417
[TBL] [Abstract][Full Text] [Related]
19. Modulating Pathogenesis with Mobile-CRISPRi.
Qu J; Prasad NK; Yu MA; Chen S; Lyden A; Herrera N; Silvis MR; Crawford E; Looney MR; Peters JM; Rosenberg OS
J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31481541
[TBL] [Abstract][Full Text] [Related]
20. Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.
Berube BJ; Murphy KR; Torhan MC; Bowlin NO; Williams JD; Bowlin TL; Moir DT; Hauser AR
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
